Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative)

STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 11, 2024	Jun. 05, 2024	May 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Expected Volatility						122.46%	112.28%
Compensation expense						$ 5,660,774
Expected Dividends						0.00%	0.00%
Expected Term							5 years 3 months 18 days
Risk Free Rate						4.29%	3.88%
Expenses for General and Administration				$ 1,943,127	$ 1,355,865	$ 8,895,978	$ 4,309,343
Expenses for Research and Developement				326,361	220,653	2,891,452	$ 1,064,563
Stock options granted							10,878
Related party accounts payable				78,101	78,101	78,101	$ 78,101
Related party cash				300,000	1,090,781	300,000	$ 1,090,781
Proceed from related party				$ 378,101		$ 1,168,882
Employee Stock Option Replacement Program [Member]
Expected Volatility						122.46%
Restricted stock were granted under the director equity plan						10,878
Outstanding number of option		230,064
Compensation expense					$ 240,750	$ 710,661
Common stock option shares approved		981,174
Compensation expense award grant				512,347
Expected Dividends						0.00%
Expected Term						10 years
Risk Free Rate						4.29%
Equity Incentive Plan the 2021 Plan [Member]
Proceed from stock issuances			$ 875,000
Incentive plan, description			the Company to such non-employee director, will not exceed $750,000 in total value or, in the event such non-employee director is first appointed or elected to the Board during such calendar year, $1,000,000 in total value
2021 Incentive Plan [Member]
Shares remain available to be issued		261,090
Stock options, issued		292,515		1,031,425		1,031,425
Incentive plan, description						the aggregate number of shares of common stock available for issuance under the 2021 Plan was 166,666 shares (following a reverse stock split); this number is automatically increased each January 1st by an amount equal to 5% of the number of common stock shares outstanding at that date, resulting in an increase in available shares under the 2021 Plan at January 1, 2024 of 119,117. On May 31, 2024, the Company’s Board of Directors amended the 2021 Plan such that the total number of shares of common stock available for issuance under the 2021 Plan was increased to 1,000,000 shares
2021 [Member] \| Black Scholes Pricing Model [Member]
Average weighted remaining contructual life in years						10 years
Common Stock Options [Member] \| Equity Incentive Plan the 2021 Plan [Member]
Awarded number of restricted stock						1,031,425
Compensation expense						$ 5,999,589
Common Stock Options [Member] \| CEO 2023 Equity Award [Member]
Expected Volatility						122.46%
Awarded number of restricted stock		50,251
Awarded number of restricted stock per share		$ 7.96
Due amount for exchange of stock option		$ 400,000
Compensation expense						$ 338,815
Expected Dividends						0.00%
Expected Term						5 years
Risk Free Rate						4.29%
Warrant [Member]
Shares issued to related parties				4,540		5,238
Common stock shares issuance				17,134		17,832
Pre-funded warrants to purchase					78,021		78,021
Warrants to purchase					499,376		499,376
38 Private Investors [Member]
Common stock shares sold to related parties						185,959
Common stock shares issuance						662,550
Cash				$ 3,099,697		$ 3,099,697
Accounts payable				$ 78,101		78,101
Proceed from related party						$ 3,177,798
Public offereing share							171,666
Proceeds from public offereing							$ 2,750,089
Director Equity Plan [Member]
Shares remain available to be issued				429,510		429,510
9 Private Investors [Member]
Common stock shares sold to related parties				45,406
Common stock shares issuance				171,364
Cash				$ 1,336,373		$ 1,336,373
Accounts payable				78,101		78,101
Proceed from related party				1,414,474
Public offereing share					171,666
Proceeds from public offereing					$ 2,750,089
Director [Member]
Compensation expense				554,321
Executives And Employee [Member]
Compensation expense				512,347
Options granted							10,878
CEO [Member]
Warrants to purchase							65,000
Stock Compensation Plan [Member]
Compensation expense				1,066,668	$ 240,750	8,728,427	$ 710,661
Expenses for General and Administration				960,432		6,561,963
Expenses for Research and Developement				106,236		2,166,464
Restricted Stock Awards [Member]
Awarded number of restricted stock issue values						$ 50,000
Awarded number of restricted stock			37,688			445,490
Awarded number of restricted stock per share			$ 7.96
Awarded number of restricted stock issue to non-employee directors	18,819					426,671
Restricted stock expense			$ 299,996
Restricted Stock Awards [Member] \| Director Stock Option Replacement Program [Member]
Restricted stock were granted under the director equity plan		127,364
Outstanding number of option		62,451
Recognized expense stock option replacement program				697,501
Awarded number of restricted stock issue values			$ 300,000
Compensation expense						$ 112,165
Restricted Stock Awards [Member] \| Stock Award in Lieu of Unpaid Directors Fees [Member]
Restricted stock were granted under the director equity plan			261,619
Recognized expense stock option replacement program				$ 458,344		$ 1,619,184
Awarded number of restricted stock per share						$ 7.96
Non-employee board members fee			$ 172,670
Description related to unpaid director fees						unpaid amounts were grossed up for taxes at an assumed tax rate of 45% and the number of shares was determined based on the Company’s closing stock price on December 29, 2023 of $1.20 per share